KLRK1 and neoplasm: Once activated, Smad2/3 enter the nucleus and regulate the expression of various molecules including NKG2D, CD71, CD98 with the ultimate effects of altering glucose uptake, cytokine production, and tumour killing (Zhao et al., 2019).